Cyclosporin in inflammatory bowel disease
- 31 March 2007
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 5 (4) , 343-350
- https://doi.org/10.1111/j.1365-2036.1991.tb00037.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Cyclosporin for Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2007
- A Placebo-Controlled, Double-Blind, Randomized Trial of Cyclosporine Therapy in Active Chronic Crohn's DiseaseNew England Journal of Medicine, 1989
- Unsatisfactory effect of cyclosporin A treatment in Crohn's disease: a report of five casesJournal of Internal Medicine, 1989
- Sandimmun® (Ciclosporin) in Autoimmune DiseasesAmerican Journal of Nephrology, 1989
- REGULATION OF GENE EXPRESSION IN LECTIN-STIMULATED OR LYMPHOKINE-STIMULATED T LYMPHOCYTES1Transplantation, 1988
- Cyclosporine Absorption in Two Patients with Short-Bowel SyndromeDrug Intelligence & Clinical Pharmacy, 1988
- 1 Cyclosporins, Fungal Metabolites with Immunosuppressive ActivitiesProgress in Medicinal Chemistry, 1988
- Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine.Proceedings of the National Academy of Sciences, 1986
- CYCLOSPORIN FOR CROHN'S DISEASEThe Lancet, 1984
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981